PL2170349T3 - Leczenie wad serca u ssaków innych niż człowiek antagonistą aldosteronu - Google Patents
Leczenie wad serca u ssaków innych niż człowiek antagonistą aldosteronuInfo
- Publication number
- PL2170349T3 PL2170349T3 PL08774270T PL08774270T PL2170349T3 PL 2170349 T3 PL2170349 T3 PL 2170349T3 PL 08774270 T PL08774270 T PL 08774270T PL 08774270 T PL08774270 T PL 08774270T PL 2170349 T3 PL2170349 T3 PL 2170349T3
- Authority
- PL
- Poland
- Prior art keywords
- treatment
- human mammals
- aldosterone antagonist
- heart deficiency
- deficiency
- Prior art date
Links
- 239000002170 aldosterone antagonist Substances 0.000 title 1
- 229940083712 aldosterone antagonist Drugs 0.000 title 1
- 230000007812 deficiency Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/42—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of mineralocorticosteroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Immunology (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Gastroenterology & Hepatology (AREA)
- Hematology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Rheumatology (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0704584A FR2917975B1 (fr) | 2007-06-26 | 2007-06-26 | Compositions et traitement de l'insuffisance cardiaque chez les animaux mammiferes non humains |
| US4841908P | 2008-04-28 | 2008-04-28 | |
| EP08774270.6A EP2170349B1 (fr) | 2007-06-26 | 2008-06-25 | Traitement de l'insuffisance cardiaque chez les animaux mammiferes non humains par un antagoniste de l'aldostérone |
| PCT/EP2008/058054 WO2009000843A2 (fr) | 2007-06-26 | 2008-06-25 | Traitement de l'insuffisance cardiaque chez les animaux mammifères non humains par un antagoniste de l'aldostérone |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2170349T3 true PL2170349T3 (pl) | 2014-01-31 |
Family
ID=38951459
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL12180375T PL2564855T3 (pl) | 2007-06-26 | 2008-06-25 | Leczenie niewydolności serca u ssaków niebędących ludźmi z użyciem antagonisty aldosteronu |
| PL12180334T PL2564854T3 (pl) | 2007-06-26 | 2008-06-25 | Leczenie niewydolności serca u ssaków niebędących ludźmi z użyciem antagonisty aldosteronu |
| PL08774270T PL2170349T3 (pl) | 2007-06-26 | 2008-06-25 | Leczenie wad serca u ssaków innych niż człowiek antagonistą aldosteronu |
| PL12180487T PL2564856T3 (pl) | 2007-06-26 | 2008-06-25 | Leczenie niewydolności serca u ssaków niebędących ludźmi z użyciem antagonisty aldosteronu |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL12180375T PL2564855T3 (pl) | 2007-06-26 | 2008-06-25 | Leczenie niewydolności serca u ssaków niebędących ludźmi z użyciem antagonisty aldosteronu |
| PL12180334T PL2564854T3 (pl) | 2007-06-26 | 2008-06-25 | Leczenie niewydolności serca u ssaków niebędących ludźmi z użyciem antagonisty aldosteronu |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL12180487T PL2564856T3 (pl) | 2007-06-26 | 2008-06-25 | Leczenie niewydolności serca u ssaków niebędących ludźmi z użyciem antagonisty aldosteronu |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20100183718A1 (pl) |
| EP (5) | EP2564854B1 (pl) |
| JP (1) | JP5876219B2 (pl) |
| AU (1) | AU2008267227B2 (pl) |
| BR (1) | BRPI0813882A2 (pl) |
| CA (1) | CA2696961C (pl) |
| ES (4) | ES2433383T3 (pl) |
| FR (1) | FR2917975B1 (pl) |
| PL (4) | PL2564855T3 (pl) |
| WO (1) | WO2009000843A2 (pl) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8980894B2 (en) | 2004-03-25 | 2015-03-17 | Boehringer Ingelheim Vetmedica Gmbh | Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure |
| EP1579862A1 (en) | 2004-03-25 | 2005-09-28 | Boehringer Ingelheim Vetmedica Gmbh | Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure |
| EP1920785A1 (en) * | 2006-11-07 | 2008-05-14 | Boehringer Ingelheim Vetmedica Gmbh | Liquid preparation comprising a complex of pimobendan and cyclodextrin |
| FR2917975B1 (fr) | 2007-06-26 | 2009-10-16 | Ceva Sante Animale Sa | Compositions et traitement de l'insuffisance cardiaque chez les animaux mammiferes non humains |
| US20090270356A1 (en) * | 2008-04-28 | 2009-10-29 | Ceva Sante Animale Sa | Compositions and treatments of heart failure in non-human mammal animals |
| PL2793866T5 (pl) * | 2011-12-21 | 2023-12-04 | Elanco Tiergesundheit Ag | Tabletka dwuwarstwowa zawierająca chlorowodorek benazeprylu i pimobendan |
| ES2924478T3 (es) | 2012-03-15 | 2022-10-07 | Boehringer Ingelheim Vetmedica Gmbh | Formulación de comprimidos farmacéuticos para el sector médico veterinario, método de producción y uso de los mismos |
| FR2991179B1 (fr) * | 2012-06-01 | 2016-11-11 | Ceva Sante Animale | Compositions veterinaires orales appetentes |
| CN105377235A (zh) | 2013-07-19 | 2016-03-02 | 勃林格殷格翰动物保健有限公司 | 含有防腐的醚化的环糊精衍生物的液体水性药物组合物 |
| KR102308973B1 (ko) | 2013-12-04 | 2021-10-08 | 베링거잉겔하임베트메디카게엠베하 | 개선된 피모벤단의 약제학적 조성물 |
| US10537570B2 (en) | 2016-04-06 | 2020-01-21 | Boehringer Ingelheim Vetmedica Gmbh | Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease |
| JP7412329B2 (ja) | 2017-08-17 | 2024-01-12 | セバ・サンテ・アニマル | 経口用組成物及びその調製方法 |
| CA3265073A1 (en) * | 2022-08-16 | 2024-02-22 | Imuneks Farma Ilac San. Ve Tic. A.S. | TREATMENT OF DISEASES CAUSED BY RNA VIRUSES |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2652761C2 (de) | 1976-11-16 | 1985-11-21 | Schering AG, 1000 Berlin und 4709 Bergkamen | 15,16-Methylen-Spirolactone, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel |
| ES8101067A1 (es) | 1978-08-25 | 1980-12-01 | Thomae Gmbh Dr K | Procedimiento para la preparacion de nuevos bencimidazoles sustituidos en posicion 5 o 6 con un anillo de piridazinona |
| FR2444047A1 (fr) * | 1978-12-13 | 1980-07-11 | Roussel Uclaf | Nouveaux derives 2,2-dimethyl 19-nor steroides, leur procede de preparation et leur application comme medicaments |
| FI77669C (fi) | 1983-04-13 | 1989-04-10 | Ciba Geigy Ag | 20-spiroxaner och analoger, som innehaoller en oeppen ring e, foerfarande foer deras framstaellning samt dessa innehaollande farmaceutiska preparat. |
| FR2569408B1 (fr) * | 1984-08-24 | 1986-10-03 | Roussel Uclaf | Nouveaux steroides substitues en position 10 par un radical comportant une double ou triple liaison, leur procede de preparation, leur application comme medicaments, les compositions pharmaceutiques les renfermant |
| FR2594829B1 (fr) * | 1986-02-24 | 1988-06-03 | Roussel Uclaf | Nouveaux steroides 9 (11) satures substitues en position 10 par un radical comportant une triple liaison, leur procede de preparation, leur application comme medicaments, les compositions pharmaceutiques les renfermant |
| GB8903130D0 (en) | 1989-02-11 | 1989-03-30 | Orion Yhtymae Oy | Substituted pyridazinones |
| JPH11507012A (ja) | 1995-02-10 | 1999-06-22 | ジー．ディー．サール アンド カンパニー | 心臓血管系病気の処置におけるアンギオテンシン変換酵素阻害薬と副作用軽減量のアルドステロン拮抗薬との組合わせ治療 |
| EP1280533A2 (en) * | 2000-05-11 | 2003-02-05 | Pharmacia Corporation | Aldosterone antagonist composition for release during aldosterone acrophase |
| OA12983A (en) * | 2001-07-19 | 2006-10-13 | Pharmacia Corp | Combination of an aldosterone receptor antagonist and an HMG COA reductase inhibitor. |
| WO2003070278A1 (en) * | 2002-02-19 | 2003-08-28 | Boehringer Ingelheim International Gmbh | Pharmaceutical combination of angiotensin ii antagonists and angiotensin i converting enzyme inhibitors |
| JP2004016070A (ja) * | 2002-06-14 | 2004-01-22 | Hitachi Ltd | オーソログ遺伝子発現分布測定用オリゴヌクレオチドアレイ |
| CA2495376A1 (en) * | 2002-08-23 | 2004-03-04 | Pharmacia Corporation | Modulation of matrix metalloproteinase (mmp) activity with aldosterone blocker(s) |
| CL2004000366A1 (es) * | 2003-02-26 | 2005-01-07 | Pharmacia Corp Sa Organizada B | USO DE UNA COMBINACION DE UN COMPUESTO DERIVADO DE PIRAZOL INHIBIDOR DE QUINASA p38, Y UN INHIBIDOR DE ACE PARA TRATAR DISFUNCION RENAL, ENFERMEDAD CARDIOVASCULAR Y VASCULAR, RETINOPATIA, NEUROPATIA, EDEMA, DISFUNCION ENDOTELIAL O INSULINOPATIA. |
| US20040214804A1 (en) * | 2003-04-25 | 2004-10-28 | Pharmacia Corporation | Combination of an aldosterone receptor antagonist and an anti-obesity agent |
| JP4783887B2 (ja) * | 2005-02-17 | 2011-09-28 | 国立大学法人大阪大学 | 心筋組織の障害を抑制するための医薬組成物 |
| FR2917975B1 (fr) | 2007-06-26 | 2009-10-16 | Ceva Sante Animale Sa | Compositions et traitement de l'insuffisance cardiaque chez les animaux mammiferes non humains |
| US20090270356A1 (en) * | 2008-04-28 | 2009-10-29 | Ceva Sante Animale Sa | Compositions and treatments of heart failure in non-human mammal animals |
-
2007
- 2007-06-26 FR FR0704584A patent/FR2917975B1/fr active Active
-
2008
- 2008-06-25 PL PL12180375T patent/PL2564855T3/pl unknown
- 2008-06-25 US US12/666,026 patent/US20100183718A1/en not_active Abandoned
- 2008-06-25 ES ES08774270T patent/ES2433383T3/es active Active
- 2008-06-25 JP JP2010513898A patent/JP5876219B2/ja active Active
- 2008-06-25 EP EP12180334.0A patent/EP2564854B1/fr active Active
- 2008-06-25 PL PL12180334T patent/PL2564854T3/pl unknown
- 2008-06-25 AU AU2008267227A patent/AU2008267227B2/en active Active
- 2008-06-25 ES ES12180375.3T patent/ES2566923T3/es active Active
- 2008-06-25 ES ES12180334.0T patent/ES2566960T3/es active Active
- 2008-06-25 EP EP12180487.6A patent/EP2564856B1/fr active Active
- 2008-06-25 EP EP08774270.6A patent/EP2170349B1/fr active Active
- 2008-06-25 CA CA2696961A patent/CA2696961C/fr active Active
- 2008-06-25 PL PL08774270T patent/PL2170349T3/pl unknown
- 2008-06-25 ES ES12180487.6T patent/ES2566924T3/es active Active
- 2008-06-25 EP EP12180375.3A patent/EP2564855B1/fr active Active
- 2008-06-25 EP EP12180415.7A patent/EP2567701A3/fr not_active Withdrawn
- 2008-06-25 WO PCT/EP2008/058054 patent/WO2009000843A2/fr not_active Ceased
- 2008-06-25 PL PL12180487T patent/PL2564856T3/pl unknown
- 2008-06-28 BR BRPI0813882-6A2A patent/BRPI0813882A2/pt not_active Application Discontinuation
-
2019
- 2019-09-20 US US16/577,025 patent/US20200016155A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| PL2564856T3 (pl) | 2016-07-29 |
| JP2010531333A (ja) | 2010-09-24 |
| PL2564855T3 (pl) | 2016-07-29 |
| ES2566924T3 (es) | 2016-04-18 |
| AU2008267227B2 (en) | 2014-05-01 |
| EP2567701A3 (fr) | 2013-07-03 |
| EP2170349A2 (fr) | 2010-04-07 |
| JP5876219B2 (ja) | 2016-03-02 |
| ES2433383T3 (es) | 2013-12-10 |
| CA2696961A1 (fr) | 2008-12-31 |
| WO2009000843A2 (fr) | 2008-12-31 |
| FR2917975B1 (fr) | 2009-10-16 |
| EP2564854A1 (fr) | 2013-03-06 |
| EP2564855A1 (fr) | 2013-03-06 |
| WO2009000843A3 (fr) | 2009-07-23 |
| US20100183718A1 (en) | 2010-07-22 |
| BRPI0813882A2 (pt) | 2015-01-13 |
| AU2008267227A1 (en) | 2008-12-31 |
| EP2567701A2 (fr) | 2013-03-13 |
| EP2170349B1 (fr) | 2013-08-07 |
| EP2564854B1 (fr) | 2016-01-20 |
| CA2696961C (fr) | 2018-07-31 |
| EP2564856B1 (fr) | 2016-01-20 |
| AU2008267227A8 (en) | 2010-02-18 |
| EP2564856A1 (fr) | 2013-03-06 |
| ES2566960T3 (es) | 2016-04-18 |
| FR2917975A1 (fr) | 2009-01-02 |
| PL2564854T3 (pl) | 2016-07-29 |
| US20200016155A1 (en) | 2020-01-16 |
| EP2564855B1 (fr) | 2016-01-20 |
| ES2566923T3 (es) | 2016-04-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL2170349T3 (pl) | Leczenie wad serca u ssaków innych niż człowiek antagonistą aldosteronu | |
| IL267138A (en) | Improved composition of cells and methods for its preparation | |
| IL240870A0 (en) | Human cardiovascular progenitor cells | |
| EP2376920A4 (en) | METHOD FOR DETECTING CHANGES IN CELLS | |
| ZA201004602B (en) | Pyrrolopyrimidines and pyrrolopyridines | |
| PL2409727T3 (pl) | Urządzenia elektroporacyjne do elektroporacji komórek u ssaków | |
| ZA201008295B (en) | Improvements in feedwells | |
| ZA201006625B (en) | In-shower and bath compositions | |
| IL212488A0 (en) | Human progenitor t-cells | |
| GB2468957B (en) | Improvements in or relating to pcb-mounted integrated circuits | |
| GB0817650D0 (en) | Improvements in the field of imaging | |
| GB0802154D0 (en) | Improvements in electrical means | |
| EP2343759A4 (en) | BATTERY COMPONENT AND BATTERY | |
| GB0616784D0 (en) | Reduction of noise in electrical field measurements | |
| EP2294245A4 (en) | ARRANGEMENT CONNECTED TO AN ALD REACTOR | |
| GB0815180D0 (en) | Improvements in or relating to insulation | |
| ZA201102911B (en) | Whey and thymus function | |
| EP2319588A4 (en) | FLAME RETARDANT DEVICE INSTALLED IN REINFORCED PLASTIC BOATS | |
| GB2473842B (en) | An electrical assembly and improvements in or relating thereto | |
| PT2316036E (pt) | Padrões de células estimuladas | |
| GB0812080D0 (en) | Human propeeled boat | |
| GB0814238D0 (en) | Enhancement of electrochemical response | |
| EP2318570A4 (en) | ELECTROLYTIC CELL AND RELATED METHODS FOR THE PRODUCTION AND USE THEREOF | |
| ZA201008384B (en) | Lasalocid compositions and methods | |
| GB0823515D0 (en) | Improvements in bivvies |